Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 11:12 am Purchase | 2022-12-30 | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | VANGUARD GROUP INC | 17,365,080 9.340% | 1,014,049 (+6.20%) | Filing History |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | BlackRock Inc. BLK | 15,206,690 8.200% | 1,185,398 (+8.45%) | Filing History |
| 2022-03-11 2:13 pm Unchanged | 2021-12-31 | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | BlackRock Inc. BLK | 14,021,292 7.600% | 0 (Unchanged) | Filing History |
| 2022-02-14 12:48 pm Purchase | 2021-12-31 | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | Dodge & Cox | 14,825,049 8.100% | 5,028,125 (+51.32%) | Filing History |
| 2022-02-10 12:21 pm Sale | 2021-12-31 | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | PRIMECAP MANAGEMENT CO/CA/ | 17,804,780 9.700% | -400,554 (-2.20%) | Filing History |
| 2022-02-09 3:33 pm Sale | 2021-12-31 | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | VANGUARD GROUP INC | 16,351,031 8.910% | -18,658 (-0.11%) | Filing History |
| 2022-02-08 5:05 pm Sale | 2021-12-31 | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | BlackRock Inc. BLK | 14,021,292 7.600% | -745,600 (-5.05%) | Filing History |
| 2022-01-10 12:04 pm Sale | 2022-01-10 | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | Capital Research Global Investors | 12,672,008 6.900% | -9,521,519 (-42.90%) | Filing History |